Journal article
Significant improvement of a nevus spilus-type congenital melanocytic nevus with oral selumetinib
Pediatric dermatology, Vol.41(5), pp.936-937
09/01/2024
DOI: 10.1111/pde.15666
PMID: 38886992
Abstract
Giant congenital melanocytic nevi (GCMN) can be cosmetically significant and can lead to melanoma. There is no standard pharmacologic treatment for GCMN. We present the case of an 8-year-old female with kaposiform lymphangiomatosis caused by an NRAS mutation whose nevus spilus-type GCMN improved on oral selumetinib.
Details
- Title: Subtitle
- Significant improvement of a nevus spilus-type congenital melanocytic nevus with oral selumetinib
- Creators
- R. Berna - University of PennsylvaniaT. Hasbun - Clínica AlemanaD. Adams - Children's Hospital of PhiladelphiaA. T. Moon - Children's Hospital of PhiladelphiaJ. R. Treat - Children's Hospital of Philadelphia
- Resource Type
- Journal article
- Publication Details
- Pediatric dermatology, Vol.41(5), pp.936-937
- DOI
- 10.1111/pde.15666
- PMID
- 38886992
- NLM abbreviation
- Pediatr Dermatol
- ISSN
- 0736-8046
- eISSN
- 1525-1470
- Publisher
- Wiley
- Number of pages
- 2
- Language
- English
- Date published
- 09/01/2024
- Academic Unit
- Dermatology
- Record Identifier
- 9984966751402771
Metrics
7 Record Views